FDA announces expansion of generic impurity investigation
The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.
List view / Grid view
The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.
The government in China has stated that small quantities of generic medicines that are legal in foreign countries will no longer be classed as “fake drugs”.
The two pharmaceutical companies are facing a legal battle after Mylan filed a new drug application for a generic of Novo Nordisk’s Victoza.
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
The report, published from CPhI Japan 2019, highlights the country as the second fastest growing mature market for solid dose drugs.
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU...
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
Colour-coded generics might help consumers differentiate between generics and branded medicines...
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
Of the 21 drugs designed for delivery directly to the female genital tract, only four have a cost-effective, generic equivalent...
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...